Successful Resolution of Litigation Concerning Diabetes Medication

August 2019

Shionogi v. Amneal Pharms. LLC

Robins Kaplan LLP served as counsel for Amneal in Hatch-Waxman patent litigation in the District of Delaware involving a number of patents related to Fortamet® (metformin hydrochloride extended-release tablets), which is indicated in adults with type 2 diabetes mellitus. The parties stipulated to dismissal in August 2019.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.

Similar Results

Back to Top